Ruffilli Ilaria, Ragusa Francesca, Benvenga Salvatore, Vita Roberto, Antonelli Alessandro, Fallahi Poupak, Ferrari Silvia Martina
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Department of Clinical and Experimental Medicine, University of Messina School of Medicine, Messina, Italy.
Front Endocrinol (Lausanne). 2017 Jun 19;8:139. doi: 10.3389/fendo.2017.00139. eCollection 2017.
Psoriasis (PsO) is a chronic relapsing/remitting autoimmune skin disease, associated with an increased risk of other autoimmune disorders. Psoriatic arthritis (PsA) is a chronic inflammatory arthritis occurring approximately in 30% of PsO patients. Sporadic cases of association between PsO and autoimmune thyroid disorders (AITDs) have been reported. However, two different recent studies did not find any association between them. In patients with PsO and PsA, an association with AITD has been shown by most of the studies in adults, but not in the juvenile form. In PsA women and men, thyroid autoimmunity [positive antithyroid peroxidase (AbTPO) antibodies, hypoechoic thyroid pattern] and subclinical hypothyroidism were more prevalent than in the general population. An association has been shown also in patients with PsO, arthritis, and inflammatory bowel disease, who have more frequently AITD. A Th1 immune predominance has been shown in early PsO, and PsA, with high serum CXCL10 (Th1 prototype chemokine), overall in the presence of autoimmune thyroiditis. This Th1 immune predominance might be the immunopathogenetic base of the association of these disorders. A raised incidence of new cases of hypothyroidism, thyroid dysfunction, positive AbTPO, and appearance of a hypoechoic thyroid pattern in PsA patients, especially in women, has been shown recently, suggesting to evaluate AbTPO levels, thyroid function, and thyroid ultrasound, especially in PsA women. Thyroid function follow-up and suitable treatments should be performed regularly in PsA female patients at high risk (thyroid-stimulating hormone within the normal range but at the higher limit, positive AbTPO, hypoechoic, and small thyroid).
银屑病(PsO)是一种慢性复发/缓解性自身免疫性皮肤病,与其他自身免疫性疾病的风险增加相关。银屑病关节炎(PsA)是一种慢性炎症性关节炎,约30%的PsO患者会发生。已有散发性PsO与自身免疫性甲状腺疾病(AITD)关联的病例报道。然而,最近两项不同的研究未发现它们之间存在任何关联。在成年PsO和PsA患者中,大多数研究表明其与AITD有关联,但在青少年患者中未发现。在患有PsA的女性和男性中,甲状腺自身免疫(抗甲状腺过氧化物酶抗体阳性、甲状腺低回声模式)和亚临床甲状腺功能减退比普通人群更普遍。在患有PsO、关节炎和炎症性肠病的患者中也显示出存在关联,这些患者更常发生AITD。在早期PsO和PsA中已显示出Th1免疫优势,血清CXCL10(Th1原型趋化因子)水平较高,总体上存在自身免疫性甲状腺炎。这种Th1免疫优势可能是这些疾病关联的免疫发病机制基础。最近已显示PsA患者,尤其是女性,甲状腺功能减退、甲状腺功能障碍、抗甲状腺过氧化物酶抗体阳性新病例的发生率升高以及甲状腺低回声模式的出现,这表明应评估抗甲状腺过氧化物酶抗体水平、甲状腺功能和甲状腺超声,尤其是在PsA女性患者中。对于高危的PsA女性患者(促甲状腺激素在正常范围内但处于较高水平、抗甲状腺过氧化物酶抗体阳性、甲状腺低回声且较小),应定期进行甲状腺功能随访并给予适当治疗。